Skip to main content
    Q

    QuidelOrtho Corp (QDEL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.21
    -0.53 (-4.93%)

    Market Cap: $736.90M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    QuidelOrtho Corp (QDEL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to QuidelOrtho are Delcath Systems (DCTH), Varex Imaging (VREX) and Quanterix (QTRX). QuidelOrtho trades at 11.9x earnings, against a median of 23.7x for the 5 of these companies with a P/E. By market cap, QuidelOrtho ranks 5th of the 13 companies on this page; Tandem Diabetes Care (TNDM) is the largest at $1.40B.

    Peer Comparison

    QDEL's ROIC of -2.9% is above the peer median of -12.3%, and its revenue growth of -11.6% is below the median of 11.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    QuidelOrtho (QDEL)$736.90M11.9x0.3x-14.2%-2.9%-11.6%0.00%
    Delcath Systems Inc (DCTH)$714.89M124.2x6.5x6.0%N/A70.7%0.00%
    Varex Imaging Corp (VREX)$768.59M16.8x0.9x2.6%6.1%3.7%0.00%
    Quanterix Corp (QTRX)$139.11MN/A0.9x-75.0%N/A-13.1%0.00%
    Pacific Biosciences of California (PACB)$611.98MN/A3.5x-81.3%-21.1%5.5%0.00%
    Cerus Corporation (CERS)$400.88MN/A1.6x-3.2%-0.2%9.5%0.00%
    Sight Sciences Inc (SGHT)$601.92MN/A6.6x-32.1%-29.0%25.2%0.00%
    Integra LifeSciences Holdings (IART)$1.12B5.5x0.7x0.8%2.1%2.3%0.00%
    Avita Medical Ltd (RCEL)$491.10MN/A5.5x-42.6%-159.3%53.1%0.00%
    Iradimed Co (IRMD)$1.09B43.5x12.1x26.9%N/A14.2%0.94%
    Senseonics Holdings, Inc. Common Stock (SENS)$579.58MN/A11.9x-204.2%-71.4%141.6%0.00%
    Tactile Systems Technology Inc (TCMD)$600.58M23.7x1.7x6.7%N/A7.1%0.00%
    Tandem Diabetes Care Inc (TNDM)$1.40BN/A1.2x-4.6%-3.4%13.8%0.00%
    Peer median$606.95M23.7x2.6x-3.9%-12.3%11.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to QuidelOrtho, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Delcath Systems Inc (DCTH)
    Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
    DCTH competitors
    Varex Imaging Corp (VREX)
    Varex Imaging Corporation designs and manufactures X-ray imaging components. The company is headquartered in Salt Lake City, Utah.
    VREX competitors
    Quanterix Corp (QTRX)
    Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research...
    QTRX competitors
    Pacific Biosciences of California (PACB)
    Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems.
    PACB competitors
    Cerus Corporation (CERS)
    Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety.
    CERS competitors
    Sight Sciences Inc (SGHT)
    Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases...
    SGHT competitors
    Integra LifeSciences Holdings (IART)
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery...
    IART competitors
    Avita Medical Ltd (RCEL)
    AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom.
    RCEL competitors
    Iradimed Co (IRMD)
    IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories...
    IRMD competitors
    Senseonics Holdings, Inc. Common Stock (SENS)
    Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United...
    SENS competitors
    Tactile Systems Technology Inc (TCMD)
    Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United...
    TCMD competitors
    Tandem Diabetes Care Inc (TNDM)
    Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United...
    TNDM competitors

    Frequently Asked Questions About QDEL

    Who are QuidelOrtho's main competitors?

    The companies most similar to QuidelOrtho include Delcath Systems (DCTH), Varex Imaging (VREX), Quanterix (QTRX), Pacific Biosciences of California (PACB) and Cerus (CERS), listed from the closest match.

    Who is QuidelOrtho's biggest competitor?

    Tandem Diabetes Care (TNDM) is the largest of the similar companies at $1.40B; Delcath Systems (DCTH) is the closest match by business profile, size, sector and industry.

    How does QDEL stock compare with its competitors?

    QDEL's P/E is 11.9x against a peer median of 23.7x; its P/S is 0.3x against a peer median of 2.6x; its net margin is -14.2% against a peer median of -3.9%.

    Which of QuidelOrtho's competitors pays a higher dividend?

    QuidelOrtho pays no dividend. Iradimed (IRMD) has a higher forward dividend yield; Iradimed (IRMD) has the highest at 0.94%.

    Is QuidelOrtho bigger than its competitors?

    No. QuidelOrtho is 5th by market cap among the 13 companies on this page; the largest is Tandem Diabetes Care (TNDM) at $1.40B.